COVID-19 Project Topics: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 5: | Line 5: | ||
{{WikiDoc CMG}}; {{AE}} {{Sahar}} | {{WikiDoc CMG}}; {{AE}} {{Sahar}} | ||
==Overview== | ==Overview== | ||
==List of All Topics== | ==List of All Topics== | ||
'''COVID-19 Organ-Based Complications''' | |||
* [[Cardiovascular Disorders and COVID-19]] | * [[Cardiovascular Disorders and COVID-19]] | ||
* [[Dermatologic Disorders of COVID-19]] | * [[Dermatologic Disorders of COVID-19]] | ||
*[[Hematologic disorders and COVID-19]] | * [[Hematologic disorders and COVID-19]] | ||
* [[Nephrologic Disorders and COVID-19]] | * [[Nephrologic Disorders and COVID-19]] | ||
* [[Neurologic Disorders and COVID-19]] | * [[Neurologic Disorders and COVID-19]] | ||
| Line 16: | Line 17: | ||
* Pediatrics and COVID-19 | * Pediatrics and COVID-19 | ||
* Radiologic Manifestations of COVID-19 | * Radiologic Manifestations of COVID-19 | ||
Revision as of 17:07, 11 June 2020
| COVID-19 Project |
|---|
| Introduction |
| Team |
| Meetings' Summary |
| Topics |
| Ongoing Clinical Trials |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sahar Memar Montazerin, M.D.[2]
Overview
List of All Topics
COVID-19 Organ-Based Complications
- Cardiovascular Disorders and COVID-19
- Dermatologic Disorders of COVID-19
- Hematologic disorders and COVID-19
- Nephrologic Disorders and COVID-19
- Neurologic Disorders and COVID-19
- Ongoing Clinical Trials of COVID-19
- Pulmonary Disorders and COVID-19
- Pediatrics and COVID-19
- Radiologic Manifestations of COVID-19